Company intelligence / Profile preview
Areva Pharmaceuticals
Georgetown, Indiana, United States
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Areva Pharmaceuticals manufactures and distributes high-quality generic pharmaceuticals, specializing in oncology injectables and oral solids for the US market. One proprietary candidate (AV-608, an NK1R antagonist) for social phobia was discontinued before approval.
- Therapeutic areas
- PsychiatryInfectious DiseasesGastroenterologyOncologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Areva Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Areva Pharmaceuticals.